S-1: Verde Resources Files S-1 for BioAsphalt IPO & Nasdaq Uplisting
Registration Statement for Public Offering
Verde Resources, a sustainable road construction materials company, files an S-1 registration statement for a public offering and Nasdaq listing, highlighting its BioAsphalt technology and exclusive licensing agreement with Ergon.
Summary
- Verde Resources is a road construction and building materials company focused on proprietary, environmentally sustainable materials, aiming for 'TransitiontoZero' emissions.
- The company's core products include BioAsphalt, which incorporates biochar for carbon sequestration, and Verde V24, a licensed cold mix biochar asphalt emulsifying agent.
- Verde expects to generate revenue from the sale of carbon removal credits (CORCs) generated by its products.
- Key milestones include the issuance of the world's first carbon removal credit from asphalt production (April 2025) and technological validation of BioAsphalt by NCAT, demonstrating consistent durability and exceeding industry specifications for cold-recycled asphalt (July and September 2025).
- An exclusive licensing agreement was signed with Ergon, a major asphalt marketer in North America, for the production of asphalt surface course material containing Verde V24 in the United States, Canada, and Mexico.
- The company plans to expand operations and revenue over the next 12 months primarily through the Ergon partnership in North America, with production planning already commenced.
- Verde operates an asset-light business model, focusing on licensing, sales, royalties, carbon monetization, and strategic partnerships.
- The company is planning a reverse stock split (1-for-[] to 1-for-[]) to meet Nasdaq listing requirements.
- Gross proceeds of $2 million were received from a private placement with Ergon on October 31, 2025, for working capital and general corporate purposes.
Sentiment
Score: 4
Explanation: While the company has significant technological validations and a strategic partnership with Ergon, its current financial performance shows substantial losses and declining revenue in the most recent quarter. The heavy reliance on a single licensee with no minimum purchase requirements initially, coupled with the need for significant future capital raises and the inherent risks of an unproven business model at scale, indicate a high-risk investment despite the promising green technology.
Positives
- Proprietary BioAsphalt technology incorporates biochar for carbon sequestration, aiming to reduce emissions, improve performance, and lower costs.
- Verde V24 cold mix biochar asphalt emulsifying agent has received technological validation from NCAT, demonstrating consistent durability and superior cohesion, tensile strength ratio (TSR), and retained stability compared to standard cold mix benchmarks.
- The company secured the world's first carbon removal credit from asphalt production and application, certified by Puro.earth, a leading global registry for engineered carbon removal.
- An exclusive 10-year licensing agreement with Ergon, a major North American asphalt leader, provides immediate scalability and near-term revenue generation in the U.S., Canada, and Mexico.
- The asset-light business model minimizes capital intensity and creates recurring revenue streams through licensing, sales, royalties, carbon monetization, and strategic partnerships.
- The company's solutions align with global Net Zero targets, Scope 1-3 emissions reductions, and climate-resilient procurement policies, positioning it as a first-mover in scalable Net Zero solutions.
- The BioFraction facility in Borneo is set to become fully operational once Malaysian expansion is ready, capable of producing up to 6,000 tons of biochar annually.
Negatives
- The company has a limited operating history in its current business model (since 2023), making future revenue and earnings difficult to evaluate.
- Verde Resources has a history of operating losses, reporting net losses of approximately $4.78 million for the fiscal year ended June 30, 2025, and $0.92 million for the three months ended September 30, 2025.
- An accumulated deficit of approximately $19.18 million was reported as of September 30, 2025.
- The company faces significant revenue concentration risk due to its reliance on Ergon as its first and currently only licensee for Verde V24.
- Under the Ergon License, there are no minimum purchase requirements for Verde V24 during the initial 15-month go-to-market period, and future minimums require good faith negotiation, creating uncertainty in revenue generation.
- The loss of key personnel, specifically CEO Jack Wong or COO Eric Bava, could lead to the termination of the Ergon License with little to no penalties.
- The company will need to raise additional capital to satisfy future capital needs and grow, with the current offering being relatively small, potentially leading to dilution for existing stockholders.
- The planned Reverse Stock Split may adversely affect the price and liquidity of the common stock, and there is no assurance it will result in a sustained increase in per-share price or successful Nasdaq listing.
- The company does not carry business interruption insurance, exposing it to unrecoverable losses in the event of operational disruptions.
Risks
- Limited operating history and evolving business model make future revenue and earnings difficult to predict.
- History of operating losses and may never achieve cash flow positive or profitable results.
- Dependence on third-party licensees (currently only Ergon) and their inability to perform or loss of these relationships would materially adversely affect the business.
- Revenue concentration risk due to reliance on Ergon as a single key customer, with no minimum purchase requirements for Verde V24 during the initial 15-month period.
- Future operating results are difficult to predict and may vary significantly from quarter to quarter, potentially affecting stock price.
- May not enter into an exclusive license agreement with Nature Plus Inc for the TerraZyme technology, requiring identification or development of a substitute.
- Inability to respond in a timely and cost-effective manner to changes in consumer preferences in the road and construction materials industry.
- Dependence on certain key personnel (Jack Wong, Eric Bava) and the risk of losing them, which could trigger Ergon License termination.
- Inability to protect proprietary technology (trade secrets) and potential exposure to intellectual property claims or litigation.
- Risk of product liability claims that could be expensive, divert management attention, and harm reputation.
- Inability to obtain raw materials (biochar) from suppliers in a timely manner, especially reliance on a single supplier for biochar in the U.S.
- Asphalt supply and price volatility, where declining asphalt prices could make traditional products more competitive.
- Exposure to risks of doing business internationally, including difficulty enforcing liabilities in foreign jurisdictions.
- Need to raise additional capital, which may dilute or subordinate existing common stockholders' rights, and inability to raise capital could cause business failure.
- Reliance on third parties for the manufacture of low-carbon asphalt products increases risks of insufficient quality, quantities, or acceptable costs.
- Complex, multi-party, multi-year projects/contracts expose the company to risks of incorrect budget forecasts, failure to meet standards, or late delivery.
- Risks relating to management's conclusion that disclosure controls and procedures and internal controls over financial reporting are ineffective.
- If unable to protect the confidentiality of trade secrets, business and competitive position would be harmed.
- Delays or interruptions in shipping products could affect operations.
- Changes in U.S. climate policy may adversely affect demand for solutions.
- Failure to continue developing and improving sustainable products may lead to falling behind competitors.
- Considerable discretion in the use of net proceeds from the offering, which may not align with investor expectations.
- Failure to meet Nasdaq continued listing requirements could result in de-listing.
- If shares are delisted from Nasdaq and become subject to penny stock rules, trading would become more difficult.
- Market price for common stock may be volatile and fluctuate, and an active market may never develop.
- Amended and restated articles of incorporation allow the Board to create new series of preferred stock without shareholder approval, potentially affecting common stock rights.
- Future sales of common stock may adversely affect market price and ability to raise funds.
- Likely experience additional, perhaps significant, dilution from future equity offerings.
- Nevada anti-takeover provisions could discourage, delay, or prevent a change in control.
- Amended and restated bylaws designate certain courts as the sole and exclusive forum for certain actions, limiting stockholders' ability to choose a favorable judicial forum.
Future Outlook
Verde Resources plans to expand operations and grow revenue over the next 12 months by marketing and selling its proprietary road technologies through Ergon exclusively in North America, with an initial focus on the United States. Production planning has commenced, with distribution anticipated through Ergon's established sales channels. The company also intends to license its Verde Net Zero Blueprint globally, targeting infrastructure and materials companies aligned with the Paris Climate Agreement and Net Zero by 2050 goals. Future revenue streams are expected from licensing, sales, royalties, carbon monetization, and strategic partnerships. The company is also engaging in R&D for national security and defense-related applications of BioAsphalt.
Management Comments
- "Our proprietary product BioAsphalt incorporates biochar, a powerful carbon sequestering material, into infrastructure with the goal of reducing emissions, improving performance, and lowering overall costs."
- "We believe our proprietary products, know-how and business plan place us at the forefront of sustainable innovation in the construction and building materials sector, an industry we believe is long overdue for transformation."
- "Our model presents a novel combination of infrastructure performance with measurable climate impact, establishing us as a first mover in scalable Net Zero solutions, which we believe positions us well to meet the demands of a rapidly decarbonizing, carbon-constrained economy."
- "Embedding our technology into Ergons nationwide business footprint would enable immediate scalability and near-term revenue generation."
- "We believe our asset light business model enables scalable growth while minimizing capital intensity, creating recurring revenue streams through licensing, sales, royalties, carbon monetization, and strategic partnerships."
- "We believe our products are positioned to lead in this transition [to sustainable solutions]."
- "We believe our ability to monetize decarbonization through a scalable, licensable model places us at the forefront of engineered carbon removal and gives us a significant first-mover advantage."
Industry Context
Verde Resources operates at the intersection of the rapidly evolving sustainable building materials and carbon removal industries. The global road construction market was valued at $572.9 billion in 2023, with North America at $188.0 billion in 2024, projected for continued growth driven by infrastructure investment and a shift towards sustainable materials. The global carbon market for carbon dioxide removal credits is expected to surge from $2.7 billion in 2023 to $100 billion by 2030-2035, driven by increasing pressure on enterprises to offset carbon footprints, especially with the rise of AI data centers. Verde's model, combining infrastructure performance with measurable climate impact and verified carbon removal credits, positions it as a first-mover in scalable Net Zero solutions. While the industry is competitive and dominated by larger players, Verde's unique asphalt-integrated biochar with verified carbon credits offers a paradigm shift rather than direct competition, allowing existing producers to transition without overhauling equipment.
Comparison to Industry Standards
- Verde's cold mix biochar asphalt has been tested by NCAT and demonstrated consistent durability, particularly under low-volume roadway conditions, after approximately 50,000 equivalent single-axle loads of heavy truck traffic.
- NCAT's latest evaluation of Verde's cold recycling mix using 100% reclaimed asphalt pavement (RAP) demonstrated superior cohesion, high tensile strength ratio (TSR), and retained stability compared to standard cold mix benchmarks, exceeding industry specifications for cold-recycled asphalt.
- The company's biochar-asphalt technology is the first carbon-sequestering asphalt surface course to maintain competitive strength and flexibility for road applications and enable verified carbon removal credits.
- Compared to traditional hot mix asphalt, Verde's cold mix biochar asphalt produces fewer emissions by eliminating high-temperature processing and requiring less electricity during manufacturing, is fully recyclable, and uses local, low-carbon raw materials.
- TerraZyme enzyme-based soil stabilization offers a low-emission, cost-effective, and rapidly deployable solution compared to conventional cement, lime, or other chemical additives, which are costly, labor-intensive, and carbon-intensive.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Financial Officer | N/A | Sherina Chui | 2025-05-01 | Appointment to leverage over two decades of financial leadership experience. |
| Director | N/A | Karl Strahl | 2025-05-01 | Appointment as a respected executive in the biochar and carbon removal industry. |
| Director | N/A | Dr. Raymond Lee Powell | 2025-07-03 | Appointment due to extensive experience in asphalt pavement research, innovation, and industry collaboration. |
| Chief Growth Officer | N/A | Jeremy P. Concannon | 2024-08-01 | Appointment to lead high-performing sales organization and implement data-driven sales strategies. |
| Chief Growth Officer | Jeremy P. Concannon | N/A | 2025-08-31 | Termination by mutual agreement between the parties. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Board Committee Formation | Upon effectiveness of the registration statement, the company will have three standing committees: Audit Committee, Compensation Committee, and Nominating and Corporate Governance Committee. | Upon effectiveness of registration statement | Enhances corporate governance structure and oversight, aligning with Nasdaq listing standards. |
| Director Independence | Dr. Raymond Lee Powell and three other prospective directors are determined to be independent under Nasdaq listing standards. The Audit Committee will consist of three independent directors, with one designated as an audit committee financial expert. | Upon effectiveness of registration statement | Strengthens board independence and financial oversight, crucial for Nasdaq listing compliance and investor confidence. |
| Code of Business Conduct and Ethics & Insider Trading Policy | The board of directors has adopted a Code of Business Conduct and Ethics and an Insider Trading Policy. | N/A (already adopted) | Establishes clear ethical guidelines and controls for company conduct and securities trading, promoting transparency and integrity. |
| Anti-Takeover Provisions | Nevada law (NRS Sections 78.411-78.444 and 78.378-78.3793) regulates business combinations and controlling interest acquisitions, which the company has not opted out of. Amended and restated articles of incorporation allow the Board to create new series of preferred stock without shareholder approval. | N/A (existing Nevada law and anticipated articles) | May delay, defer, or discourage changes in control or management, potentially reducing vulnerability to hostile takeovers but also inhibiting fluctuations in stock price from takeover attempts. |
| Forum Selection Clauses | Amended and restated bylaws designate Nevada state or federal courts as the sole and exclusive forum for certain corporate actions and U.S. federal district courts for Securities Act claims. | Anticipated prior to consummation of offering | May limit stockholders' ability to choose a favorable judicial forum for disputes, potentially discouraging certain lawsuits against the company and its management. |
Legal Proceedings
- The company is not involved in any material legal proceedings.
- The company is not aware of any threatened legal proceedings or any in which a director, officer, or affiliate is an adverse party or has a material adverse interest.
Related Party Transactions
- Sale of property: CEO Jack Wong purchased a property from Verde Renewables Inc. for $857,500 on December 10, 2024, with payment in equal installments over 26 pay cycles. A gain on disposal of $161,156 was recognized.
- Settlement of debt by shares: On August 16, 2024, 9,655,542 restricted shares were issued to Borneo Oil Berhad (a related party, ultimate holding company of Borneo Oil Corporation Sdn Bhd) to settle a $675,888 promissory note.
- Amount due to director: As of September 30, 2025, $107,830 was due to CEO Jack Wong, representing the remaining balance of a $1.25 million special bonus, with monthly installments deducted from the bonus.
- Amounts due to related parties: As of September 30, 2025, various amounts totaling $325,125 were due to Borneo Oil Corporation Sdn Bhd ($72,866), Borneo Oil Berhad ($3,007), Taipan International Limited ($119,153), Borneo Energy Sdn Bhd ($16,374), Victoria Capital Sdn Bhd ($5,931), Makin Teguh Sdn Bhd ($19,379), J. Ambrose & Partners ($75,985), SB Resorts Sdn Bhd ($6,642), SB Supplies & Logistics Sdn Bhd ($4,626), and Borneo Eco Food Sdn. Bhd. ($1,162). These advances are related to ordinary business transactions, bear no interest or collateral, and are repayable on demand.
- Amount due from a related party: As of June 30, 2025, $100 was due from Vetrolysis Limited (director Encik Anuar bin Ismail is an indirect significant shareholder). This balance was $0 as of September 30, 2025.
- Consulting services agreement: On November 29, 2024, Verde Renewables entered into a consulting services agreement with AUM Media Inc. (AUM) for capital markets, investor relations, and media relations advice. The company agreed to issue shares equivalent to 9,313,100 restricted shares (0.75% of total shares outstanding) to AUM or its designee. 4,656,550 shares were issued to Aegis Ventures Limited (AUM's designee) on January 2, 2025, with the remaining 4,656,550 shares to be issued upon Nasdaq listing.
Stakeholder Impact
- Shareholders: Potential for dilution from the current public offering and future capital raises. The Reverse Stock Split could negatively impact stock price and liquidity. Nasdaq listing could increase visibility and liquidity but is not assured. Existing shareholders are subject to a 6-month lock-up period.
- Employees: Compensation includes stock awards, which could be impacted by stock price volatility. The company is dependent on key personnel, and their retention is critical for business continuity and the Ergon License.
- Customers (licensees like Ergon): Benefit from exclusive licensing of proprietary technologies and access to carbon removal credits. Their success in commercializing BioAsphalt directly impacts Verde's revenue streams. Ergon's ability to meet minimum purchase amounts (post-go-to-market period) is crucial.
- Suppliers (e.g., C-Twelve, Oregon Biochar Solutions): C-Twelve receives licensing fees and a loan, and potential conditional fee payments. Oregon Biochar Solutions is in negotiations for a formal supply agreement. Their ability to provide quality raw materials is vital for product production.
- Regulatory Authorities: The company's products and carbon credits are subject to certification and compliance with environmental laws and construction material standards. Nasdaq listing requires adherence to specific corporate governance and financial standards.
Next Steps
- Effect a reverse stock split (1-for-[] to 1-for-[]) to meet Nasdaq minimum bid price requirements.
- Complete the Nasdaq Capital Market listing application process.
- Fund the $2 million C-Twelve Loan and $1 million exclusive licensing fee to C-Twelve within 30 days of Nasdaq listing, or by July 31, 2026, to avoid breach.
- Continue on-boarding matters and testing of Verde V24 within Ergon's products, with commercial market launch anticipated in early calendar year 2026.
- Negotiate definitive supply agreement with Oregon Biochar Solutions for custom blend biochar in Q1 2026.
- Establish nationwide distribution and deployment across multiple asphalt plants with Ergon, with early sales-based revenues expected between April 2026 and September 2026.
- Initiate discussions regarding minimum quantities with Ergon for 2027, starting October 2026.
- Expand the licensing model to establish commercial partnerships in new global markets and regions, particularly Southeast Asia.
- Engage in further research and development to deliver new technologies and products, including potential national security and defense-related applications for BioAsphalt.
- Restart and increase operations at the BioFraction facility in Borneo once Malaysian expansion is ready, targeting major Malaysian highway operators.
- Explore licensing BioFraction intellectual property to palm oil waste processors in Southeast Asia.
Key Dates
| Date | Description |
|---|---|
| 2022-12-15 | Services Agreement with Looi Pei See to develop retail markets in Malaysia and Singapore. |
| 2022-12-31 | Issuance of 1,140,000 restricted shares to Looi Pei See for services. |
| 2023-03-13 | Settlement of Debts Agreement with Champmark Sdn Bhd and Borneo Oil Corporation Sdn Bhd for a $675,888 promissory note. |
| 2023-04-21 | Issuance of 1,909,339 shares for a private placement. |
| 2023-09-08 | Service and Stock Cancellation Agreement with Steven Sorhus, resulting in cancellation of 171,591 non-vested shares. |
| 2023-09-08 | Service and Stock Cancellation Agreement with EMGTA LLC to cancel 375,000 restricted shares (still in process). |
| 2023-09-12 | Service and Stock Cancellation Agreement with Y M Tengku Chanela Jamidah Y A M Tengku Ibrahim, resulting in cancellation of 333,333 non-vested shares. |
| 2023-10-01 | Eric Bava appointed Chief Operating Officer. |
| 2023-10-23 | Services Agreement with Donald R. Fosnacht as National Certification and Extensive BCR Implementation Specialist. |
| 2023-11-22 | Issuance of 14,931,624 restricted shares to twenty-five shareholders via private placement. |
| 2023-12-04 | Issuance of 1,238,889 restricted shares to five shareholders via private placement. |
| 2024-01-31 | Issuance of 1,000,000 restricted shares to Donald R. Fosnacht. |
| 2024-02-26 | Issuance of 555,555 shares for a private placement. |
| 2024-03-28 | Cancellation of 300,000 shares related to Steven Sorhus and 500,000 shares related to Y M Tengku Chanela Jamidah Y A M Tengku Ibrahim. |
| 2024-03-30 | Jack Wong re-elected as Director. |
| 2024-04-12 | Issuance of 2,881,274 restricted shares to four non-U.S. shareholders. |
| 2024-04-15 | Issuance of 200,000 restricted shares to one U.S. shareholder. |
| 2024-04-15 | Issuance of 3,055,555 restricted shares to four U.S. shareholders. |
| 2024-04-20 | Services Agreements with Dr. Nam Tran and Dr. Raymond Powell as National Implementation Experts. |
| 2024-05-24 | Re-issuance of 128,409 shares to Steven Sorhus and 166,667 shares to Y M Tengku Chanela Jamidah Y A M Tengku Ibrahim. |
| 2024-06-01 | Multi-year Services Agreement with Dale Ludwig as Strategic Advisor. |
| 2024-06-27 | Agreement with NCAT for a 3-year Performance Testing Project on Structural Capacity of Sustainable Pavement. |
| 2024-07-24 | Issuance of 9,199,443 shares to twenty-five shareholders via private placement. |
| 2024-07-31 | Issuance of 1,000,000 restricted shares each to Dr. Nam Tran and Dr. Raymond Powell. |
| 2024-07-31 | Employment Agreement with Jeremy P. Concannon as Chief Growth Officer. |
| 2024-08-01 | Jeremy P. Concannon appointed Chief Growth Officer. |
| 2024-08-08 | Issuance of 700,000 restricted shares to Dale Ludwig. |
| 2024-08-09 | Issuance of 12,728,888 shares to twenty-five shareholders via private placement. |
| 2024-08-14 | Memorandum of Understanding (NPI MOU) with Nature Plus Inc. for TerraZyme technology collaboration. |
| 2024-08-16 | Issuance of 9,655,542 restricted shares to Borneo Oil Berhad to settle a promissory note. |
| 2024-08-26 | Issuance of 4,712,221 shares to eleven shareholders via private placement. |
| 2024-08-30 | Issuance of 1,350,000 restricted shares to Jeremy P. Concannon. |
| 2024-08-30 | Issuance of 670,000 restricted shares to Eric Bava. |
| 2024-08-31 | Jeremy P. Concannon's Employment Agreement terminated by mutual agreement. |
| 2024-09-16 | Issuance of 572,222 shares to three shareholders via private placement. |
| 2024-10-16 | Formation of VerdePlus Inc. subsidiary in partnership with NPI. |
| 2024-10-16 | Issuance of 800,000 shares to three shareholders via private placement. |
| 2024-10-18 | Binding Term Sheet with C-Twelve Pty Ltd for exclusive license of proprietary binder and biochar asphalt mixed designs. |
| 2024-11-27 | Cancellation of 450,000 restricted shares previously issued to two U.S. shareholders. |
| 2024-11-29 | Consulting services agreement with AUM Media Inc. as Capital Markets, Investor Relations and Media Relations Advisor. |
| 2024-12-10 | Sale of Chesterfield Property to CEO Jack Wong for $857,500. |
| 2024-12-19 | Transfer of title for Chesterfield Property completed. |
| 2025-01-02 | Issuance of 4,656,550 restricted shares to Aegis Ventures Limited (AUM's designee). |
| 2025-01-02 | Issuance of 3,277,775 shares to thirteen shareholders via private placement. |
| 2025-01-03 | Issuance of 50,000 restricted shares to Hannah Bruehl. |
| 2025-01-06 | Cancellation of 200,000 restricted Common Shares previously issued to two U.S. shareholders. |
| 2025-01-17 | Purchase and Sale Agreement with TAFleer Properties LLC for the sale of La Belle, Missouri property for $350,000. |
| 2025-01 | Disposition of La Belle, Missouri property completed. |
| 2025-02-18 | Issuance of 3,905,555 shares to nine shareholders via private placement. |
| 2025-04 | Issuance of the world's first carbon removal credit from asphalt production and application, certified by Puro.earth. |
| 2025-04-22 | Cancellation of 150,000 restricted Common Shares previously issued to one U.S. shareholder. |
| 2025-05-01 | Sherina Chui appointed Chief Financial Officer. |
| 2025-05-01 | Karl Strahl appointed Director. |
| 2025-05-19 | Definitive Joint Development Agreement (C-Twelve Agreement) with C-Twelve Pty Ltd. |
| 2025-05-20 | Issuance of 249,999 shares to two shareholders via private placement. |
| 2025-06-01 | Issuance of 1,500,000 restricted shares to Sundeo Pty Ltd (C-Twelve's designee). |
| 2025-06-01 | Issuance of 350,000 restricted shares to Karl Strahl. |
| 2025-07-01 | Issuance of 7,744,445 restricted shares to non-U.S. and U.S. shareholders for $664,000. |
| 2025-07-01 | Issuance of second tranche of 1,000,000 restricted shares to Dr. Raymond Powell. |
| 2025-07-03 | Dr. Raymond Powell appointed as a member of the board of directors. |
| 2025-07-28 | Issuance of 187,500 restricted shares to one U.S. shareholder for $15,000. |
| 2025-07 | Preliminary performance results from NCAT for Cold-Mix Biochar-Asphalt test section received, demonstrating consistent durability. |
| 2025-09-12 | Issuance of 5,412,500 restricted shares to three non-U.S. shareholders for $433,000. |
| 2025-09 | NCAT's latest evaluation of cold recycling mix using 100% RAP further validated proprietary formulation, exceeding industry specifications. |
| 2025-10-08 | Addendum to C-Twelve Agreement, expanding exclusive territory to U.S., Canada, Mexico, and agreeing to additional $1 million licensing fees and $2 million loan. |
| 2025-10-10 | Exclusive license agreement (Ergon License) with Ergon for Verde V24 in U.S., Canada, and Mexico. |
| 2025-10-10 | Non-binding term sheet with Ergon for a $2 million equity investment. |
| 2025-10-15 | Intellectual Property Transfer Agreement: BRL transferred Catalytic BioFraction Process IP to VRAP. |
| 2025-10-19 | BRL administratively dissolved. |
| 2025-10-31 | Securities Purchase Agreement (Ergon Purchase Agreement) with Ergon for 24,943,876 shares and a warrant for 24,943,876 shares, for $2 million gross proceeds. |
| 2025-12-18 | Last reported price of common stock on OTCQB was $0.0489 per share. |
| 2025-12-23 | Date of S-1 filing. |
| 2026-01-01 | Start of calendar year for Ergon to negotiate minimum purchase amounts for Verde V24. |
| 2026-07-31 | Deadline for funding the C-Twelve Loan and additional $1 million fee; failure to meet this could result in C-Twelve holding the company in breach. |
| 2026-09-30 | Termination of prohibition on Ergon selling shares from private placement if Nasdaq uplist has not occurred. |
| 2026-12-31 | NPI MOU for TerraZyme technology effective until this date, or until replaced by a definitive agreement. |
| 2027-01-01 | Start of calendar year for Ergon to negotiate minimum purchase amounts for Verde V24. |
| 2027-04-30 | Termination date for Services Agreements with Dr. Nam Tran and Dr. Raymond Powell. |
| 2027-09-30 | Termination date for Eric Bava's Employment Agreement. |
| 2027-09-30 | Termination date for Jeremy P. Concannon's Services Agreement. |
Recommendation
holdVerde Resources presents a compelling long-term vision with its innovative BioAsphalt technology and verified carbon removal credits, positioning it as a first-mover in sustainable infrastructure. The strategic partnership with Ergon, a major industry player, provides a crucial pathway for commercialization and scalability in North America. However, the company's current financial performance is weak, marked by significant operating losses and a sharp decline in revenue and gross profit in the most recent quarter, attributed to a product transition. There is substantial revenue concentration risk with Ergon, and the absence of minimum purchase requirements in the initial phase creates uncertainty. The need for future capital raises and the potential adverse effects of the planned reverse stock split on stock price and liquidity add to the speculative nature of the investment. While the long-term potential is significant, the immediate financial challenges and execution risks warrant a 'hold' recommendation, advising investors to monitor commercialization progress, financial stability, and successful Nasdaq uplisting before considering further investment.
Keywords
BioAsphalt, Carbon Removal Credits, Sustainable Infrastructure, Biochar, Verde V24, Ergon, Nasdaq Uplisting, SEC S-1, Green Technology, Road Construction, Climate-tech, Carbon Sequestration, Cold Mix Asphalt, TerraZyme, Renewable Commodities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.